Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Enterobacterales Bloodstream Infection: a Systematic Review and Meta-Analysis

Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Enterobacterales Bloodstream Infection: a Systematic Review and Meta-Analysis

ABSTRACT Several clinicians use ceftazidime-avibactam (CAZ-AVI) to treat bloodstream infections (BSIs) due to carbapenem-resistant Enterobacterales (CRE), although no conclusive data support this practice. We aimed to assess the efficacy and safety of CAZ-AVI in the treatment of CRE bacteremia. PubM...

Full description

Bibliographic Details
Main Authors: Yan Chen, Hui-Bin Huang, Jin-Min Peng, Li Weng, Bin Du
Format: Article
Language:English
Published: American Society for Microbiology 2022-04-01
Series:Microbiology Spectrum
Subjects:
ceftazidime-avibactam
carbapenem-resistant Enterobacterales
bloodstream infection
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02603-21

Similar Items

Similar Items